Conditions: Cancer; NSCLC; Melanoma; Urothelial Carcinoma; MSI-H; Head and Neck Cancer
Intervention: Drug: APX005M
Sponsor: Apexigen, Inc.
Recruiting - verified May 2017
http://ift.tt/2qB1qGe
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου